DrugPatentWatch Database Preview
Details for Patent: 8,372,431
Which drugs does patent 8,372,431 protect, and when does it expire?
Patent 8,372,431 protects APTIOM and is included in one NDA.
This patent has thirty-one patent family members in twenty-three countries.
Summary for Patent: 8,372,431
| Title: | Pharmaceutical composition comprising licarbazepine acetate |
| Abstract: | A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also disclosed is a granulation process, especially a wet granulation process, for making the pharmaceutical composition. |
| Inventor(s): | Cardoso de Vasconcelos; Teofilo (S. Mamede do Coronado, PT), dos Santos Lima; Ricardo Jorge (S. Mamede do Coronado, PT), Cerdeira de Campos Costa; Rui (S. Mamede do Coronado, PT) |
| Assignee: | BIAL-Portela & C.A., S.A. (S. Mamede do Coronado, PT) |
| Application Number: | 12/257,240 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,372,431 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Device; Dosage form; |
Drugs Protected by US Patent 8,372,431
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunovion Pharms Inc | APTIOM | eslicarbazepine acetate | TABLET;ORAL | 022416-001 | Nov 8, 2013 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Sunovion Pharms Inc | APTIOM | eslicarbazepine acetate | TABLET;ORAL | 022416-002 | Nov 8, 2013 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Sunovion Pharms Inc | APTIOM | eslicarbazepine acetate | TABLET;ORAL | 022416-003 | Nov 8, 2013 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Sunovion Pharms Inc | APTIOM | eslicarbazepine acetate | TABLET;ORAL | 022416-004 | Nov 8, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,372,431
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 069031 | Start Trial | |||
| Australia | 2008317584 | Start Trial | |||
| Brazil | PI0818680 | Start Trial | |||
| Canada | 2703313 | Start Trial | |||
| China | 101848698 | Start Trial | |||
| Cyprus | 1118350 | Start Trial | |||
| Denmark | 2214636 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
